Abraxis Biosciences files complaint against SPARC in US District Court

21 Aug 2019 Evaluate

Abraxis Biosciences LLC has filed a complaint against Sun Pharma Advanced Research Company (SPARC) in the US District Court for the district of New Jersey. It alleged that the SPARC’s filing of New Drug Application (NDA) for Taclantis injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

124.65 -4.70 (-3.63%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 542.55
Indegene 474.00
CMS Info Systems 319.15
Sagility 51.76
Smartworks Coworking 438.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×